dr. liu on the use of bevacizumab in newly diagnosed advanced ovarian cancer
Published 5 years ago • 277 plays • Length 1:45Download video MP4
Download video MP3
Similar videos
-
1:12
dr. herzog on the optimal use of bevacizumab in patients with ovarian cancer
-
4:03
upfront bevacizumab in advanced ovarian cancer
-
6:04
when to add bevacizumab for recurrent ovarian cancer
-
1:40
dr. burger on the toxicity profile of bevacizumab in ovarian cancer
-
8:15
bevacizumab in ovarian cancer
-
7:32
bevacizumab for recurrent ovarian cancer
-
8:05
targeted therapy options for advanced ovarian cancer
-
46:59
dr kyle orwig, fertility & male nb patients
-
1:08
dr. burger on the use of bevacizumab in ovarian cancer
-
1:36
dr. tew evaluates bevacizumab treatment in ovarian cancer
-
4:54
impact of solo-1 on advanced ovarian cancer management
-
3:13
dr. herzog on the fda approval of olaparib/bevacizumab as frontline maintenance in ovarian cancer
-
1:47
dr. liu on parp inhibitors in recurrent ovarian cancer
-
4:54
bevacizumab in recurrent ovarian cancer
-
5:17
ovarian cancer: a new indication for bevacizumab
-
1:38
dr. liu on cediranib/olaparib in recurrent ovarian cancer
-
5:41
bevacizumab’s role in recurrent ovarian cancer
-
1:11
dr. ledermann on the additive effects of olaparib and bevacizumab in ovarian cancer
-
1:19
dr. essel discusses adverse events of bevacizumab in ovarian cancer